NADH
Coenzyme 1
Snapshot
| Indications | Contraindications |
|---|---|
Reduced nicotinamide adenine dinucleotide (NADH) is the electron-carrying coenzyme that feeds the mitochondrial electron transport chain to generate adenosine triphosphate (ATP)5. Supplementation aims to support cellular energy, mainly for fatigue in myalgic encephalomyelitis/chronic fatigue syndrome, alone or with coenzyme Q10 (CoQ10)1, 6. Smaller bodies of work cover anxiety, exercise heart rate, and insulin sensitivity3.
Systematic reviews report fatigue reductions with NADH and with NADH plus CoQ10, but conclude the evidence is insufficient given small, heterogeneous studies1, 6. In a 2026 mouse model of mitochondrial progeria, nicotinamide riboside improved cardiac contractility but caused NADH accumulation and worsened anemia; no human trial has tested this. More than 600 products listing NADH are sold, mostly capsules, with lozenges and tablets also available; see Form comparison.
Reviews describe NADH as well tolerated, with muscle pain, sleep disturbance, and headache most common and none serious3. Per product labeling, people with diabetes or hypoglycemia, those taking medication, and those planning surgery are told to consult a doctor first4.
Last updated October 15, 2026. Read how we make monographs.
In the full monograph
46 sources, 31 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systematic Review.pubmed.ncbi.nlm.nih.govDorczok, Mittmann, Mossaheb et al. · Nutrients · 2025 · Pubmed
- 2Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial.pubmed.ncbi.nlm.nih.govCastro-Marrero, Sáez-Francàs, Segundo et al. · Clinical nutrition (Edinburgh, Scotland) · 2016 · Pubmed
- 3Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review.pubmed.ncbi.nlm.nih.govGindri, Ferrari, Pinto et al. · American journal of physiology. Endocrinology and metabolism · 2024 · Pubmed
- 4US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 5NADH supplementation improves human oocyte maturation and developmental competence of resulting embryos in controlled ovarian hyperstimulation cycles: a pilot study implicating the CDK2/GAS6 signaling pathway.pubmed.ncbi.nlm.nih.govZhang, Yang, Yang et al. · Frontiers in endocrinology · 2025 · Pubmed
- 6Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.pubmed.ncbi.nlm.nih.govCampagnolo, Johnston, Collatz et al. · Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2017 · Pubmed